SCLX - Scilex Holding Co

7.24
0.410   5.663%

Share volume: 26,788
Last Updated: 04-22-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.23%

PREVIOUS CLOSE
CHG
CHG%
$6.83
0.41
0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
34%
Profitability 43%
Dept financing 43%
Liquidity 4%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
4.25%
1 Month
-1.50%
3 Months
-34.12%
6 Months
-50.38%
1 Year
78.33%
2 Year
641.27%
Key data
Stock price
$7.24
P/E Ratio 
0.00
DAY RANGE
$6.92 - $7.28
EPS 
-$24.77
52 WEEK RANGE
$3.92 - $34.27
52 WEEK CHANGE
$63.43
MARKET CAP 
136.888 M
YIELD 
N/A
SHARES OUTSTANDING 
7.585 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-12-2025
BETA 
2.85
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$66,127
AVERAGE 30 VOLUME 
$44,647
Company detail
CEO: Jaisim Shah
Region: US
Website: scilexholding.com
Employees: 80
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

Vickers Vantage Corp. I does not have significant operations. The company was incorporated in 2020 and is based in Singapore. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or reorganization.

Recent news